Sitafloxacin-Based Third-Line Eradication of H. pylori

被引：0
|
作者：
Suzuki, Hidekazu
Matsuzaki, Juntaro
Nishizawa, Toshihiro
Saito, Yoshimasa
Hirata, Kenro
Tsugawa, Hitoshi
Muraoka, Hiroe
Hibi, Toshifumi
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
M1139
引用
收藏
页码：S340 / S340
页数：1
相关论文
共 50 条
  • [1] Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan
    Furuta, Takahisa
    Sugimoto, Mitsushige
    Kodaira, Chise
    Nishino, Masafumi
    Yamade, Mihoko
    Uotani, Takahiro
    Sahara, Shu
    Ichikawa, Hitomi
    Yamada, Takanori
    Osawa, Satoshi
    Sugimoto, Ken
    Watanabe, Hiroshi
    Umemura, Kazuo
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (03) : 487 - 493
  • [2] Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan
    Hirata, Yoshihiro
    Ohmae, Tomoya
    Yanai, Ayako
    Sakitani, Kosuke
    Hayakawa, Yoku
    Yoshida, Shuntaro
    Sugimoto, Takafumi
    Mitsuno, Yuzo
    Akanuma, Masao
    Yamaji, Yutaka
    Ogura, Keiji
    Maeda, Shin
    Koike, Kazuhiko
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (04) : 352 - 355
  • [3] Sitafloxacin for Third-Line Helicobacter pylori Eradication: A Systematic Review
    Nishizawa, Toshihiro
    Munkjargal, Munkhbayar
    Ebinuma, Hirotoshi
    Toyoshima, Osamu
    Suzuki, Hidekazu
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [4] Clinical Usefulness of Sitafloxacin-Based Triple Therapy as a Third Line Regimen for Helicobacter pylori Eradication in Japan
    Hirata, Yoshihiro
    Ohmae, Tomoya
    Yanai, Ayako
    Sakitani, Kosuke
    Hayakawa, Yoku
    Yoshida, Shuntaro
    Sugimoto, Takafumi
    Maeda, Shin
    Koike, Kazuhiko
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S879 - S879
  • [5] Third-line Rescue Therapy with Levofloxacin Based Protocol for H. pylori Eradication in Children
    Eren, Makbule
    Dinleyici, Ener Cagri
    Hekim, Selda
    [J]. JOURNAL OF PEDIATRIC INFECTION, 2009, 3 (03): : 98 - 103
  • [6] DIVIDING HIGH-DOSE PPI/SITAFLOXACIN-BASED TRIPLE HELICOBACTOR PYLORI ERADICATION THERAPY IS USEFULNESS AS THIRD-LINE THERAPY IN JAPANESE: PRELIMINARY STUDY
    Uotani, T.
    Sugimoto, M.
    Ichikawa, H.
    Sahara, S.
    Furuta, T.
    [J]. HELICOBACTER, 2013, 18 : 134 - 134
  • [7] Third-Line Eradication Therapy With Sitafloxacin (STFX) for Helicobacter pylori Infection and Predictive Factors for Successful Eradication
    Kato, Chieko
    Sugiyama, Toshiro
    Fujinami, Haruka
    Kajiura, Shinya
    Nshikawa, Jun
    Minemura, Masami
    Mase, Daisuke
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S579 - S579
  • [8] Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen
    Hirata, Yoshihiro
    Serizawa, Takako
    Shichijo, Satoki
    Suzuki, Nobumi
    Sakitani, Kosuke
    Hayakawa, Yoku
    Yamada, Atsuo
    Koike, Kazuhiko
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 51 : 66 - 69
  • [9] 10-Year Trends inHelicobacter pyloriEradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy
    Mori, Hideki
    Suzuki, Hidekazu
    Matsuzaki, Juntaro
    Masaoka, Tatsuhiro
    Kanai, Takanori
    [J]. DIGESTION, 2020, 101 (05) : 644 - 650
  • [10] Triple therapy of vonoprazan, amoxicillin and sitafloxacin is useful third-line regimen for Helicobacter pylori eradication in Japan
    Shimoyama, T.
    Chinda, D.
    Fukuda, S.
    [J]. HELICOBACTER, 2017, 22
12345